Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 07-Nov-11 4:24 PM View:  | Billet van Director | Caliper Life Sciences, Inc. (CALP) | 07-Nov-11 | Disposition | 25,107 | $10.50 | $263,624.00 | (100%) 25.11K to 0 | < 1% |
| 07-Nov-11 4:27 PM View: | Carter David Warren Director | Caliper Life Sciences, Inc. (CALP) | 07-Nov-11 | Disposition | 184,589 | $10.50 | $1,938,180.00 | (83%) 222.76K to 38.17K | < 1% |
| 07-Nov-11 4:40 PM View: | Kruka William C. Sr VP Corporate Development | Caliper Life Sciences, Inc. (CALP) | 07-Nov-11 | Disposition | 82,240 | $10.50 | $863,520.00 | (100%) 82.24K to 0 | < 1% |
| 07-Nov-11 4:26 PM View: | Bishop Robert C Director | Caliper Life Sciences, Inc. (CALP) | 07-Nov-11 | Disposition | 26,814 | $10.50 | $281,547.00 | (100%) 26.81K to 0 | < 1% |
| 07-Nov-11 4:36 PM View: | Creager Stephen E Sr. VP and General Counsel | Caliper Life Sciences, Inc. (CALP) | 07-Nov-11 | Disposition | 43,953 | $10.50 | $461,506.00 | (100%) 43.95K to 0 | < 1% |
| 07-Nov-11 4:46 PM View: | Milligan David V Director | Caliper Life Sciences, Inc. (CALP) | 07-Nov-11 | Disposition | 81,729 | $10.50 | $858,154.00 | (100%) 81.73K to 0 | < 1% |
| 07-Nov-11 4:39 PM View: | Hrusovsky E Kevin President & CEO Director | Caliper Life Sciences, Inc. (CALP) | 07-Nov-11 | Disposition | 826,725 | $10.50 | $8,680,610.00 | (100%) 826.73K to 0 | < 1% |
| 07-Nov-11 4:37 PM View: | Griffith Joseph H. Iv VP, Finance & Controller | Caliper Life Sciences, Inc. (CALP) | 07-Nov-11 | Disposition | 33,287 | $10.50 | $349,514.00 | (100%) 33.29K to 0 | < 1% |
| 07-Nov-11 4:22 PM View: | Bal Bruce J Sr.VP, Operations | Caliper Life Sciences, Inc. (CALP) | 07-Nov-11 | Disposition | 126,279 | $10.50 | $1,325,930.00 | (100%) 126.28K to 0 | < 1% |
| 07-Nov-11 4:48 PM View: | Tunstall Kathryn Director | Caliper Life Sciences, Inc. (CALP) | 07-Nov-11 | Disposition | 25,107 | $10.50 | $263,624.00 | (100%) 25.11K to 0 | < 1% |
| 07-Nov-11 4:34 PM View: | Comstock Allan L Director | Caliper Life Sciences, Inc. (CALP) | 07-Nov-11 | Disposition | 26,107 | $10.50 | $274,124.00 | (100%) 26.11K to 0 | < 1% |
| 07-Nov-11 4:27 PM View: | Carter David Warren Director | Caliper Life Sciences, Inc. (CALP) | 07-Nov-11 | Disposition | 38,173 | $10.50 | $400,816.00 | (100%) 38.17K to 0 | < 1% |
| 07-Nov-11 4:45 PM View: | McAree Peter F Sr.VP and CFO | Caliper Life Sciences, Inc. (CALP) | 07-Nov-11 | Disposition | 62,786 | $10.50 | $659,253.00 | (100%) 62.79K to 0 | < 1% |
| 07-Nov-11 4:43 PM View: | Manyak David M Exec VP, Drug Discovery Svcs | Caliper Life Sciences, Inc. (CALP) | 07-Nov-11 | Disposition | 423,242 | $10.50 | $4,444,040.00 | (100%) 423.24K to 0 | < 1% |
| 01-Nov-11 4:39 PM View: | Creager Stephen E Sr. VP and General Counsel | Caliper Life Sciences, Inc. (CALP) | 01-Nov-11 | Market Sale (Planned) | 5,000 | $10.47 | $52,344.50 | (10%) 48.95K to 43.95K | (< 1%) |
| 02-Nov-11 4:44 PM View: | Hrusovsky E Kevin President & CEO Director | Caliper Life Sciences, Inc. (CALP) | 31-Oct-11 | Option Exercise | 179,407 | $5.17 | $928,250.00 | 35% 505.41K to 684.82K | |
| 03-Oct-11 4:50 PM View: | Creager Stephen E Sr. VP and General Counsel | Caliper Life Sciences, Inc. (CALP) | 03-Oct-11 | Market Sale (Planned) | 5,000 | $10.45 | $52,250.00 | (9%) 53.95K to 48.95K | < 1% |
| 01-Sep-11 4:20 PM View: | Creager Stephen E Sr. VP and General Counsel | Caliper Life Sciences, Inc. (CALP) | 01-Sep-11 | Market Sale (Planned) | 5,000 | $7.52 | $37,602.00 | (9%) 56.1K to 51.1K | < 1% |
| 02-Nov-11 4:44 PM View: | Hrusovsky E Kevin President & CEO Director | Caliper Life Sciences, Inc. (CALP) | 09-Aug-11 | Option Exercise | 2,472 | $6.79 | $16,784.90 | < 1% 644.85K to 647.32K | 54% |
| 24-Aug-11 5:02 PM View: | Carter David Warren Director | Caliper Life Sciences, Inc. (CALP) | 01-Aug-11 | Exercise (in-the money or at-the-money) | 30,167 | $6.79 | $204,834.00 | 16% 192.59K to 222.76K | |
| 24-Aug-11 5:02 PM View: | Carter David Warren Director | Caliper Life Sciences, Inc. (CALP) | 01-Aug-11 | Exercise (in-the money or at-the-money) | 17,371 | $6.79 | $117,949.00 | 10% 175.22K to 192.59K | |
| 02-Aug-11 4:31 PM View: | Creager Stephen E Sr. VP and General Counsel | Caliper Life Sciences, Inc. (CALP) | 01-Aug-11 | Market Sale (Planned) | 5,000 | $8.20 | $41,007.00 | (8%) 61.1K to 56.1K | (3%) |
| 24-Aug-11 5:02 PM View: | Carter David Warren Director | Caliper Life Sciences, Inc. (CALP) | 15-Jul-11 | Exercise (in-the money or at-the-money) | 26,152 | $6.79 | $177,572.00 | 19% 141.07K to 167.22K | |
| 24-Aug-11 5:02 PM View: | Carter David Warren Director | Caliper Life Sciences, Inc. (CALP) | 15-Jul-11 | Exercise (in-the money or at-the-money) | 8,006 | $6.79 | $54,360.70 | 5% 167.22K to 175.22K | |
| 13-Jul-11 4:51 PM View: | Carter David Warren Director | Caliper Life Sciences, Inc. (CALP) | 12-Jul-11 | Exercise (in-the money or at-the-money) | 1,082 | $6.79 | $7,346.78 | < 1% 139.98K to 141.07K | |
| 13-Jul-11 4:51 PM View: | Carter David Warren Director | Caliper Life Sciences, Inc. (CALP) | 11-Jul-11 | Exercise (in-the money or at-the-money) | 2,787 | $6.29 | $17,519.10 | 2% 137.2K to 139.98K | |
| 05-Jul-11 4:23 PM View: | McAree Peter F Sr.VP and CFO | Caliper Life Sciences, Inc. (CALP) | 01-Jul-11 | Market Sale (Planned) | 5,000 | $8.10 | $40,475.00 | (8%) 64.89K to 59.89K | (< 1%) |
| 05-Jul-11 4:41 PM View: | Griffith Joseph H. Iv VP, Finance & Controller | Caliper Life Sciences, Inc. (CALP) | 01-Jul-11 | Payment of Exercise | 397 | $8.12 | $3,223.64 | (1%) 33.68K to 33.29K | (< 1%) |
| 05-Jul-11 4:15 PM View: | Creager Stephen E Sr. VP and General Counsel | Caliper Life Sciences, Inc. (CALP) | 01-Jul-11 | Market Sale (Planned) | 5,000 | $8.11 | $40,543.50 | (8%) 66.1K to 61.1K | (< 1%) |
| 15-Jun-11 4:39 PM View: | Manyak David M Exec VP, Drug Discovery Svcs | Caliper Life Sciences, Inc. (CALP) | 14-Jun-11 | Market Sale | 18,902 | $7.54 | $142,587.00 | (4%) 439.11K to 420.21K | (< 1%) |
| 15-Jun-11 4:39 PM View: | Manyak David M Exec VP, Drug Discovery Svcs | Caliper Life Sciences, Inc. (CALP) | 13-Jun-11 | Market Sale | 1,098 | $7.56 | $8,300.88 | (< 1%) 440.21K to 439.11K | (< 1%) |
| 09-Jun-11 4:26 PM View: | Manyak David M Exec VP, Drug Discovery Svcs | Caliper Life Sciences, Inc. (CALP) | 09-Jun-11 | Market Sale | 10,000 | $7.48 | $74,800.00 | (2%) 450.21K to 440.21K | 4% |
| 09-Jun-11 4:26 PM View: | Manyak David M Exec VP, Drug Discovery Svcs | Caliper Life Sciences, Inc. (CALP) | 08-Jun-11 | Market Sale | 15,000 | $7.18 | $107,700.00 | (3%) 465.21K to 450.21K | (< 1%) |
| 07-Jun-11 4:30 PM View: | Comstock Allan L Director | Caliper Life Sciences, Inc. (CALP) | 03-Jun-11 | Option Exercise | 4,375 | $7.20 | $31,500.00 | 20% 21.73K to 26.11K | (2%) |
| 07-Jun-11 4:33 PM View: | Carter David Warren Director | Caliper Life Sciences, Inc. (CALP) | 03-Jun-11 | Option Exercise | 4,375 | $7.20 | $31,500.00 | 3% 132.82K to 137.2K | (2%) |
| 07-Jun-11 4:32 PM View: | Bishop Robert C Director | Caliper Life Sciences, Inc. (CALP) | 03-Jun-11 | Option Exercise | 6,250 | $7.20 | $45,000.00 | 30% 20.56K to 26.81K | (2%) |
| 07-Jun-11 4:31 PM View: | Billet van Director | Caliper Life Sciences, Inc. (CALP) | 03-Jun-11 | Option Exercise | 4,375 | $7.20 | $31,500.00 | 21% 20.73K to 25.11K | (2%) |
| 07-Jun-11 4:39 PM View: | Milligan David V Director | Caliper Life Sciences, Inc. (CALP) | 03-Jun-11 | Option Exercise | 4,375 | $7.20 | $31,500.00 | 21% 20.73K to 25.11K | (2%) |
| 07-Jun-11 4:40 PM View: | Tunstall Kathryn Director | Caliper Life Sciences, Inc. (CALP) | 03-Jun-11 | Option Exercise | 4,375 | $7.20 | $31,500.00 | 21% 20.73K to 25.11K | (2%) |
| 02-Jun-11 4:32 PM View: | Manyak David M Exec VP, Drug Discovery Svcs | Caliper Life Sciences, Inc. (CALP) | 01-Jun-11 | Market Sale | 15,000 | $7.18 | $107,700.00 | (3%) 480.21K to 465.21K | (< 1%) |
| 26-May-11 4:27 PM View: | Manyak David M Exec VP, Drug Discovery Svcs | Caliper Life Sciences, Inc. (CALP) | 25-May-11 | Market Sale | 15,000 | $7.08 | $106,200.00 | (3%) 495.21K to 480.21K | < 1% |
| 05-Apr-11 4:22 PM View: | Hrusovsky E Kevin President & CEO Director | Caliper Life Sciences, Inc. (CALP) | 04-Apr-11 | Payment of Exercise | 8,750 | $6.80 | $59,500.00 | 1% 631.84K to 640.59K | (8%) |
| 04-Apr-11 4:23 PM View: | Creager Stephen E Sr. VP and General Counsel | Caliper Life Sciences, Inc. (CALP) | 01-Apr-11 | Market Sale (Planned) | 5,000 | $6.66 | $33,305.50 | (7%) 71.1K to 66.1K | |
| 04-Apr-11 4:25 PM View: | McAree Peter F Sr.VP and CFO | Caliper Life Sciences, Inc. (CALP) | 01-Apr-11 | Market Sale (Planned) | 5,000 | $6.70 | $33,490.00 | (7%) 69.89K to 64.89K | |
| 07-Mar-11 4:46 PM View: | Bal Bruce J Sr.VP, Operations | Caliper Life Sciences, Inc. (CALP) | 07-Mar-11 | Payment of Exercise | 1,429 | $6.57 | $9,388.53 | (1%) 127.71K to 126.28K | < 1% |
| 07-Mar-11 4:57 PM View: | McAree Peter F Sr.VP and CFO | Caliper Life Sciences, Inc. (CALP) | 07-Mar-11 | Payment of Exercise | 1,350 | $6.57 | $8,869.50 | (2%) 74.14K to 72.79K | 1% |
| 07-Mar-11 4:54 PM View: | Hrusovsky E Kevin President & CEO Director | Caliper Life Sciences, Inc. (CALP) | 07-Mar-11 | Payment of Exercise | -- | $6.57 | -- | 0% 631.84K | |
| 07-Mar-11 4:47 PM View: | Creager Stephen E Sr. VP and General Counsel | Caliper Life Sciences, Inc. (CALP) | 07-Mar-11 | Payment of Exercise | 1,651 | $6.57 | $10,847.10 | (2%) 75.6K to 73.95K | 1% |
| 07-Mar-11 4:55 PM View: | Kruka William C. Sr VP Corporate Development | Caliper Life Sciences, Inc. (CALP) | 07-Mar-11 | Payment of Exercise | 1,651 | $6.57 | $10,847.10 | (2%) 81.43K to 79.78K | 1% |
| 07-Mar-11 4:56 PM View: | Manyak David M Exec VP, Drug Discovery Svcs | Caliper Life Sciences, Inc. (CALP) | 07-Mar-11 | Payment of Exercise | 1,470 | $6.57 | $9,657.90 | (< 1%) 499.71K to 498.24K | 1% |
